Market News / Story
Why Is ARGX Stock Plunging Today?
Stocktwits ·
Stocktwits reports: Shares of Argenx (ARGX) plummeted nearly 15% in pre-market trading on Thursday after the biotech company announced it would discontinue development of its autoimmune disease treatment after a late-stage trial showed disappointing results. ARGX shares are on track for their worst single-day performance since December 2023. If the pre-market levels hold after the opening bell, the stock would fall below its 200-day moving average (200-DMA) for the first time in more than…